Skip to page content

Intellectual Property

Report
Business Community Support for U.S. Policies Toward China
Policies implemented by the Trump administration were designed to confront China over its problematic behaviors, such as theft of technology and intellectual property. U.S. businesses agreed with the policies, but questioned some of the tactics used. How can Washington address corporate concerns and still compete against China?
May 16, 2022
Report
Managing Intellectual Property Relevant to Operating and Sustaining Major U.S. Air Force Weapon Systems
Expanded reliance on original equipment manufacturers have led the U.S. Air Force to give less priority to acquiring appropriate intellectual property. What organizational change should the Air Force consider to better acquire and use intellectual property?
Sep 14, 2021
Blog
Vaccine Hesitancy, Working from Home, Arctic Diplomacy: RAND Weekly Recap
This weekly recap focuses on vaccine hesitancy as a symptom of ‘Truth Decay,’ how to make remote work beneficial for all, U.S. Arctic diplomacy, and more.
May 21, 2021
Commentary
Vaccine Patents Debate Risks Becoming a Sideshow
As COVID-19 cases continue to surge around the world, the debate is raging over whether patents on existing vaccines should be waived. But the global community could view patent waivers as just one of many available tools for speeding up vaccine delivery worldwide.
May 17, 2021
Commentary
Scientific Research Integrity Demands Transparency—the Law Should Require It Too
China pays U.S. scientists for their innovations in exchange for money and access to research laboratories and speaking and publication opportunities. They require the researchers to keep these agreements secret from their employers or the U.S. government. Perhaps it is time to codify scientific transparency into law.
Apr 12, 2021
Commentary
Needed: A Blueprint for a Post-Vaccine World
When a COVID-19 vaccine is developed, many in rich countries may be able to afford it while the poor and uninsured may not. The time to plan for equitable access, financing, intellectual property rights, and global production is now.
May 11, 2020
Report
The Role of Intellectual Property in U.S. Homeland Security
Researchers assessed intellectual property (IP) support at the U.S. Department of Homeland Security (DHS) and its components and found underused opportunities but also issues that expose programs to substantial risk.
Sep 19, 2019
Report
How Has the Israel-China Relationship Evolved?
Since the early 2000s, relations between China and Israel have expanded in areas like diplomacy, trade, investment, construction, educational partnerships, scientific cooperation, and tourism. What challenges does the relationship pose for Israel and the United States?
Mar 21, 2019
Dissertation
Patenting and Innovation in China: Incentives, Policy, and Outcomes
Explores the drivers behind China's patent boom, the impact of patenting-promoting policies, and the innovative outcomes of Chinese firms.
Mar 6, 2015
Commentary
ACTA Revisited? TTIP and Data Privacy
The EU has embarked on negotiations with the U.S. on the TTIP, which shares some of ACTA's goals. This time, though, the European Commission is seeking to make the talks more transparent by publishing a series of position papers on key issues very early on in the process. This is a step in the right direction toward an agreement that will have economic benefits for a net-exporting region of intellectual property such as the EU.
Nov 26, 2014
Commentary
A New Model for Open Innovation: The Structural Genomics Consortium
Open innovation is often suggested as a solution to enhance productivity in under-performing areas of research. Now, the strengths and weaknesses of a new open innovation model in drug discovery have been evaluated.
Mar 25, 2014
News Release
The Structural Genomics Consortium, an Innovative Open-Access, Public–Private Partnership, Is a Viable Model for Drug ...
The Structural Genomics Consortium is a viable model for drug discovery that appeals to investors, not least for advantages in efficiency over current models of public or commercial health research.
Mar 10, 2014
Report
Structural Genomics Consortium Offers Knowledge Platform for Drug Discovery
An independent evaluation of the Structural Genomics Consortium (SGC) examined the strengths and weaknesses of its efforts to support drug discovery efforts through a unique, open access model of public-private collaboration.
Mar 10, 2014
Report
The Structural Genomics Consortium: A knowledge platform for drug discovery: A summary
This report summarises the results of an independent evaluation of the Structural Genomics Consortium, an open access model of public-private collaboration, conducted by RAND Europe with the Institute on Governance.
Mar 10, 2014
Commentary
The Costs of Counterfeiting
Efforts to come to grips with intellectual property rights aren't dying down after the European Parliament voted down the Anti-Counterfeiting Trade Agreement (ACTA) last summer. Indeed, the need for evidence of the scale and impact of counterfeiting has only become more pressing. A RAND Europe report points to a potential solution and has already been dubbed
Nov 28, 2012
News Release
New Method for Estimating Costs of Counterfeiting Presented
A new method for estimating the costs of counterfeiting was published today by RAND Europe. The approach uses market data to estimate the effects of intellectual property rights infringements, such as counterfeit products, on sales of legitimate goods.
Sep 27, 2012
Report
A New Approach to Measure Intellectual Property Rights Infringements
Globalization, integrated markets, and the Internet economy have contributed to the rise in IPR infringements. RAND developed a methodology based on economic theory to contribute to quantifying the scope, scale, and impact of IPR infringements, such as counterfeiting, unauthorized downloads, and piracy.
Sep 27, 2012
Report
Intellectual Property and Developing Countries: A review of the literature
This report examines the impact of intellectual property rights in developing countries, in the context of the World Trade Organization's Agreement on Trade-Related Intellectual Property Rights (TRIPS) and the development of TRIPS-plus standards.
Feb 22, 2010
Journal Article
Intellectual Property and Marketing
Patent protection spurs innovation by raising the rewards for research, but it usually results in less desirable allocations after the innovation has been discovered.
Jan 1, 2006
Report
Innovation and Intellectual Property: The Case of Genomic Patenting
Explores the potential effect on future innovation in biotechnology of a patent on a gene, which may cover a wide range of possible technological applications and be of unknown breadth when issued.
Jan 1, 2003

1
2
Next